Back
Krystal Biotech Vs. Madrigal Pharmaceuticals Industry Stock Comparison
Sell
33
KRYS
Krystal Biotech
Last Price:
181.25
Seasonality Move:
29.78%
Sell
41
MDGL
Madrigal Pharmaceuticals
Last Price:
209.27
Seasonality Move:
31.83%
Sell
33
Krystal Biotech (KRYS)
is a Sell
Is Krystal Biotech a Buy, Sell or Hold?
- The current Krystal Biotech [KRYS] share price is $182.03. The Score for KRYS is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- KRYS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Madrigal Pharmaceuticals (MDGL)
is a Sell
Is Madrigal Pharmaceuticals a Buy, Sell or Hold?
- The current Madrigal Pharmaceuticals [MDGL] share price is $212.11. The Score for MDGL is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- MDGL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KRYS Stock Price Chart
What is Krystal Biotech's stock price today?
-
The Krystal Biotech share price today is $182.03
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KRYS is experiencing buying pressure, which is a positive indicator for future bullish movement.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals's stock price today?
-
The Madrigal Pharmaceuticals share price today is $212.11
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MDGL is experiencing slight selling pressure.
KRYS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.69 | Sell |
| Relative Strength Index (14 RSI): | 44.34 | Sell |
| Chaikin Money Flow: | 108853 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (180.83 - 196.53) | Sell |
| Bollinger Bands (100): | (168.75 - 199.33) | Sell |
MDGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -9.65 | Sell |
| Relative Strength Index (14 RSI): | 30.25 | Sell |
| Chaikin Money Flow: | -167075 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (223.2 - 248.2) | Sell |
| Bollinger Bands (100): | (227.73 - 277.27) | Sell |
KRYS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 180.71 | Buy |
| 20-day SMA: | 186.21 | Sell |
| 50-day SMA: | 192.21 | Sell |
| 200-day SMA: | 164.16 | Buy |
| 8-day EMA: | 181.51 | Buy |
| 20-day EMA: | 185.63 | Sell |
| 50-day EMA: | 188 | Sell |
| 200-day EMA: | 166.91 | Buy |
MDGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 222.39 | Sell |
| 20-day SMA: | 231.75 | Sell |
| 50-day SMA: | 248.81 | Sell |
| 200-day SMA: | 242.59 | Sell |
| 8-day EMA: | 220.04 | Sell |
| 20-day EMA: | 230.1 | Sell |
| 50-day EMA: | 242.65 | Sell |
| 200-day EMA: | 238.47 | Sell |
Krystal Biotech Earnings Growth & KRYS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.98 per share, and an increase next year of $1.95 per share.
Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $3.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $9.33 per share, and an increase next year of $10.92 per share.
Krystal Biotech Technical Analysis
| Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Madrigal Pharmaceuticals Technical Analysis
| Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||